Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|
EPS | $0.0 | ($0.4) | ($0.2) | ($1.0) | $0.1 | $51.9 | $40.1 | $4.1 |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, BioNTech SE's last 12-month EPS is ($2.1), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, BioNTech SE's EPS growth was N/A. The average annual EPS growth rates for BioNTech SE have been N/A over the past three years, 28.6% over the past five years.